LEXINGTON, Mass.--(BUSINESS WIRE)--Inotek Pharmaceuticals Corporation (NASDAQ: ITEK), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies for ocular diseases, today announced three poster presentations at the Association for Research in Vision and Ophthalmology (ARVO) 2016 Annual Meeting to be held May 1-5 at the Washington State Convention Center. The presentation details are as follows:
